TheWealthWeb

ICICI Prudential Nifty Pharma ETF

ICICI Prudential Mutual FundExchange Traded Funds (ETFs) - Other ETFRegular · GrowthRisk: Very High

NAV ₹28.5248 on 13 November 2026

NAV performance, last year

Returns

To 13 November 2026. Up to 1 year: total change. 3 and 5 years: compound return a year.

PeriodThis fundNIFTY PHARMA TRI
1M-+9.46%
6M-+19.86%
1Y-+26.54%
3Y-+23.39%
5Y-+16.53%

Benchmark: NIFTY PHARMA TRI (total return index), measured over the same dates.

Costs and fund facts

Exit load
Nil
Benchmark
NIFTY PHARMA TRI
Allotment date
23 October 2026Scheme document
Type
Open Ended
AMFI scheme code
154804

Investment objective

The objective of the investment scheme is to provide returns before expenses that closely correspond to the total return of the underlying index, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

From the scheme summary document filed with AMFI.

SIP calculator

A monthly SIP replayed on this fund's actual daily NAVs: what it would be worth today.

Monthly SIP Amount₹10,000
Investment Horizon5 Years
Simulating monthly 1st from 26 Oct 2026 to 13 Nov 2026
Total Invested2 mos
₹20,000
Units: 757.31
Current Portfolio Value
₹21,602
At latest recorded NAV
Total Profit
+₹1,602
+8.0% absolute return
SIP XIRR
593.53%
Annualised, money-weighted
Wealth CompositionProfit is 8% of total invested capital
Invested: ₹20,000Profit Generated: ₹1,602
Same SIP in the benchmark (NIFTY PHARMA TRI)Same dates & amounts
Scheme SIP Valuation
₹21,602
593.5% XIRR
Benchmark SIP Valuation
₹10,34,998
21.3% XIRR
Fund minus benchmark
₹-10,13,396
Over 2 monthly installments
SIP instalments are bought on the first NAV date of each month; values use the latest NAV we hold. Past returns are not a guide to future returns.

About this fund

ICICI Prudential Nifty Pharma ETF is a mutual fund scheme from ICICI Prudential Mutual Fund, listed by AMFI under “Exchange Traded Funds (ETFs) - Other ETF”. Its NAV was ₹28.5248 on 13 November 2026. For an index fund or ETF, how closely it tracks its index matters more than its rank against other passive funds. The fund house rates its risk as “Very High” on the SEBI riskometer. Its scheme summary document gives the allotment date as 23 October 2026.

Figures are calculated from AMFI NAVs and index data, not taken from fund factsheets. Methodology. Past performance is not a guide to future returns. Compare tracking difference across index funds.